User profiles for Muzaffer Onur Turan

muzaffer onur turan

izmir katip çelebi university
Verified email at ikc.edu.tr
Cited by 653

Evaluation of inhaler technique and patient satisfaction with fixed-combination budesonide/formoterol dry-powder inhaler in chronic obstructive pulmonary disease …

…, MO Turan, C Demir, Ş Torun, M Cirit, M Turan… - Tuberkuloz ve …, 2012 - europepmc.org
Results Patients were characterized by prominence of moderate to severe (78.1%) COPD,
high rate of regular use of overall COPD medications (89.4%) and Turbuhaler® for an …

[HTML][HTML] Presence of headache and migraine in asthma patients

MO Turan, ÇÇ Susuz, PA Turan - Turkish thoracic journal, 2017 - ncbi.nlm.nih.gov
OBJECTIVES Migraine is a diseases characterized with severe headaches, with neurological
and systemic findings. The purpose of this study is to investigate the prevalence of …

Chronic obstructive pulmonary disease phenotypes in Turkey: the COPET study-a national, multicenter cross-sectional observational study

…, G GÜLBAŞ, MO TURAN… - Turkish journal of …, 2022 - journals.tubitak.gov.tr
Background/aim: While mortality rates decrease in many chronic diseases, it continues to
increase in COPD. This situation has led to the need to develop new approaches such as …

Evaluation of patients with COVID-19 receiving long-term oxygen support in post-COVID period

MO Turan, F Bozkus, O Batum, SA Alkan… - Chest, 2021 - journal.chestnet.org
PURPOSE: COVID-19 can lead to hypoxemia as a result of damage due to inflammatory
responses to SARS-CoV-2 in the respiratory system. Persistent post-COVID syndrome, may …

Characteristics of our hypoxemic COVID-19 pneumonia patients receiving corticosteroids and mortality-associated factors

…, P Mutlu, Ö Özdemir, C Satıcı, MO Turan… - Expert Review of …, 2022 - Taylor & Francis
Background COVID-19 is a disease associated with diffuse lung injury that has no proven
effective treatment yet. It is thought that glucocorticoids may reduce inflammation-mediated …

[PDF][PDF] COVID-19 Pandemisinde Astım, Kronik Obstrüktif Akciğer Hastalığı ve Eşlik Eden Komorbiditelerin Yönetimi: Sistematik Derleme.

MO TURAN, EG BALBAY, K AKSU… - … Klinikleri Archives of …, 2022 - researchgate.net
Koronavirüs hastalığı-2019 [coronavirus disease-2019 (COVID-19)] pandemisinde, astım ve
kronik obstrüktif akciğer hastalığı (KOAH) hastaları için COVID-19 gelişme riskinde belirgin …

[HTML][HTML] Avaliação de padrões pressóricos Dipper e Não-Dipper e qualidade de vida entre pacientes com doença pulmonar obstrutiva crônica

M Askın, EM Koc, K Sozmen, MO Turan… - Arquivos Brasileiros …, 2021 - SciELO Brasil
Fundamento O padrão pressórico não-dipper é definido por uma redução inferior a 10% na
pressão arterial noturna e está associado a doenças cardiovasculares. Acredita-se que a …

[HTML][HTML] Evaluation of Dipper and Non-dipper Blood Pressure Patterns and Quality of Life Among Patients with Chronic Obstructive Pulmonary Disease

M Askın, EM Koc, K Sozmen, MO Turan… - Arquivos Brasileiros …, 2021 - SciELO Brasil
Fundamento O padrão pressórico não-dipper é definido por uma redução inferior a 10% na
pressão arterial noturna e está associado a doenças cardiovasculares. Acredita-se que a …

[PDF][PDF] Safety Evaluation and Tolerability Overview of Favipiravir in the Management of COVID-19: A Real-Life Experience from Turkey

…, V Avkan-Oğuz, AN Yalçın, G Polat, MO Turan… - 2024 - cms.istanbulmedicaljournal.org
Introduction: Coronavirus diseases-2019 (COVID-19) have been ongoing for more than two
years. Despite the scientific research conducted in this process, there is still no widely …

Factors that may affect FEV1 Change of COPD patients in one-year period

MO TURAN, PA TURAN, A MİRİCİ - Medical Research Reports, 2020 - dergipark.org.tr
INTRODUCTION: One of the hallmarks of COPD is the rate of FEV1 decline. There are many
factors that may affect pulmonary parameters in a COPD patient. It was aimed to investigate …